AG真人官方

SentinelOne, Inc. has filed a Form 144 indicating a planned sale of 2,427 Class A shares through broker Raymond James & Associates. The proposed transaction is valued at $43,686 based on the market price stated in the filing and represents approximately 0.0008 % of the company鈥檚 318.3 million shares outstanding. The filer acquired the shares on 12 December 2020 via a 鈥渟tock conversion before IPO.鈥� The anticipated sale date is 07 July 2025 on the NYSE. No sales were reported in the prior three months and no material adverse information was indicated by the seller.

DeFi Development Corp. (Nasdaq: DFDV) filed an 8-K disclosing the completion of a private placement of $112.5 million aggregate principal amount of 5.50% Convertible Senior Notes due 2030. The notes were sold at par to qualified institutional buyers under Rule 144A; the initial purchasers hold an additional $25 million option. Net proceeds were approximately $108.1 million after underwriting discounts and expenses.

Use of proceeds: roughly $75.6 million funded a privately negotiated prepaid forward stock purchase for about 3.6 million DFDV shares, effectively executing an accelerated buy-back. Remaining funds are earmarked for general corporate purposes, including the planned acquisition of Solana.

Key note terms:

• Interest: 5.50% payable semi-annually on 1 Jan and 1 Jul, beginning 1 Jan 2026.
• Maturity: 1 Jul 2030.
• Conversion: prior to 1 Jan 2030 only upon specified events; after that date, at any time until two trading days before maturity.
• Initial conversion rate: 43.2694 shares per $1,000 (鈮� $23.11/share); maximum conversion rate with adjustments is 47.5963 shares, implying potential issuance of up to 5,354,584 shares.
• Redemption: not callable before 5 Jul 2026; thereafter redeemable at par plus accrued interest if the stock trades 鈮�150% of the conversion price for 20 out of 30 consecutive trading days.
• Fundamental change put: holders may require 100% repurchase plus accrued interest.

The accompanying Indenture with U.S. Bank Trust Company establishes standard covenants and default provisions. The prepaid forward transaction is separate from the notes, transferring any future dividends on the repurchased shares back to the company.

Investor takeaways: The financing injects over $100 million of capital at a fixed 5.5% cost, offsets near-term dilution through the share buy-back, but introduces leverage and potential future equity issuance if the notes convert.

Clover Health Investments, Corp. (CLOV) has filed a Form 144 indicating a proposed sale of insider shares.

• Shares to be sold: 2,012 common shares
• Estimated market value: $5,150.72
• Broker: Morgan Stanley Smith Barney LLC, New York
• Planned execution date: 07/07/2025 on NASDAQ
• Total shares outstanding: 416,541,578 (sale equals ~0.0005% of float)

The filing also lists recent 10b5-1 sales by the same insider, Jamie Reynoso, totaling 40,239 shares for gross proceeds of $109,504.30 across two transactions on 06/17/2025 and 07/03/2025.

Because the proposed sale is immaterial relative to the company鈥檚 share count, the market impact is expected to be minor; however, continual insider selling can be perceived negatively by some investors.

Sunrun Inc. (RUN) Form 144 filing: An insider has notified the SEC of an intent to sell 8,909 common shares, valued at about $96,261, through broker Charles Schwab on or after 07 Jul 2025. The shares stem from the lapse of restricted stock units (RSUs) received as equity compensation. The filing also discloses that the same seller disposed of 18,531 shares in two transactions during the past three months, generating gross proceeds of roughly $127,337. The proposed sale represents less than 0.01% of Sunrun鈥檚 228.5 million shares outstanding and, by itself, is unlikely to be material to the company鈥檚 capital structure.

SentinelOne Director Mark S. Peek received two significant equity awards on June 25, 2025:

1. 4,174 deferred restricted stock units (DSUs) with quarterly vesting schedule:

• 25% vests each on Sept 15, Dec 15, March 15
• Final installment vests by June 15, 2026
• Settlement deferred per Director Compensation Program

2. 12,522 restricted stock units (RSUs) vesting on earliest of:

• June 25, 2026
• Next annual stockholder meeting
• Death, disability, or change in control

Following these transactions, Peek owns 65,609 shares directly (subject to vesting) and 80,000 shares indirectly through a trust. All awards contingent on continued service as director.

SentinelOne Director Aaron Hughes reported new equity grants on June 25, 2025, receiving two separate restricted stock unit (RSU) awards:

• 3,339 deferred RSUs with quarterly vesting schedule (25% each on Sept 15, Dec 15, March 15, and final installment by June 15, 2026)
• 12,522 standard RSUs vesting fully on June 25, 2026 or earlier upon certain events

Following these transactions, Hughes beneficially owns 63,090 shares of Class A Common Stock directly. The RSU grants were made under SentinelOne's Non-Employee Director Compensation Program, with zero acquisition cost. The deferred RSUs include special settlement terms, while the standard RSUs will vest fully upon events including death, disability, or change in control, subject to continued service.

SentinelOne (ticker S) filed a Form 4 disclosing that non-employee director Daniel Scheinman received an equity grant of 12,522 restricted stock units (RSUs) on 06/25/2025. The award carries a $0 acquisition price and will automatically vest on the earlier of June 25 2026, the next annual shareholder meeting, the director鈥檚 death or disability, or a change in control, provided he remains in service until that date.

Following the grant, Scheinman鈥檚 direct holdings increased to 62,029 Class A shares; an additional 28,150 shares are held indirectly through the Dan and Zoe Scheinman Family Trust. Certain shares remain subject to forfeiture if vesting conditions are not met. No open-market purchase or sale occurred, and there is no cash consideration, making this a routine board compensation event rather than a market transaction.

SentinelOne director Charlene T. Begley received two equity awards on June 25, 2025:

• 3,895 deferred restricted stock units (DSUs) with quarterly vesting of 25% each on September 15, December 15, March 15, and final installment by June 15, 2026
• 12,522 restricted stock units (RSUs) vesting fully on June 25, 2026 or earlier upon certain events

Following these transactions, Begley owns 74,816 shares directly and 1,395 shares indirectly through three trusts (465 shares each). The DSUs and RSUs are subject to continued service requirements and will settle according to the Non-Employee Director Compensation Program terms. Some shares remain subject to forfeiture if vesting conditions are not met.

SentinelOne director Ana G. Pinczuk received two equity grants on June 25, 2025:

• 3,116 deferred restricted stock units (DSUs) that vest quarterly at 25% intervals on September 15, December 15, March 15, and June 15, 2026 (or earlier based on next annual meeting). Settlement is deferred per the Director Compensation Program.
• 12,522 restricted stock units (RSUs) that fully vest on June 25, 2026, or earlier upon certain events including the next annual meeting, death, disability, or change in control.

Following these transactions, Pinczuk beneficially owns 70,551 shares of Class A Common Stock directly, with some shares subject to forfeiture if vesting conditions are not met. Both equity grants were issued at $0 cost and represent part of the company's non-employee director compensation structure.